Study of rivastigmine for delirium in intensive care is stopped after deaths.
Tony
T
Sheldon
D014150:Antipsychotic Agents / Q000627:therapeutic use; D003422:Critical Care; D003645:Death, Sudden; D003693:Delirium / Q000188:drug therapy*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D015337:Multicenter Studies as Topic; D018696:Neuroprotective Agents / Q000009:adverse effects*; D048448:Phenylcarbamates / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic; D000068836:Rivastigmine
D014150:Antipsychotic Agents; D018696:Neuroprotective Agents; D048448:Phenylcarbamates; D006220:Haloperidol; D000068836:Rivastigmine